amivantamab
SpainDrugs containing this active substance
-
It is used in adults with a type of lung cancer called non-small cell lung cancer, when the cancer has spread to other parts of the body and presents certain changes in a gene called EGFR. It may be prescribed as a first-line treatment in combination with lazertinib or when chemotherapy is no longer effective.
Form: solution for injection
Active substance Dosage amivantamab 1600 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults with a type of lung cancer called non-small cell lung cancer, when the cancer has spread to other parts of the body and has certain genetic changes in a gene called EGFR. It may be used as first treatment in combination with lazertinib or when chemotherapy is no longer effective.
Form: solution for injection
Active substance Dosage amivantamab 2240 mg Manufacturer: Janssen-Cilag International N.V
-
It is used in adults with a type of lung cancer called non-small cell lung cancer, specifically when the cancer has spread to other parts of the body and presents certain mutations in the EGFR gene.
Form: solution for infusion, concentrate
Active substance Dosage amivantamab 350 mg Manufacturer: Janssen-Cilag International N.V